Delivery Order SPE2DB24D2106-SPE2DB25FAWEE
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,986.59 by the Defense Logistics Agency on September 8, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30. This delivery order, which carries no set-aside designation, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,892.75 by the Defense Logistics Agency on September 23, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This delivery order was issued without a set-aside designation and carries an ultimate completion date of September 24, 2025. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1.74K on September 22, 2025, by the Defense Logistics Agency for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This delivery order carries a firm fixed-price structure with an ultimate completion date of September 23, 2025, and was issued without a set-aside designation. The delivery will be performed at the...
- The Defense Logistics Agency awarded a $3,052.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Ondansetron ODT 4 mg tablets (30-count packaging) on August 12, 2025, with completion targeted for August 13, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026. The place of performance is Conshohocken, Pennsylvania. No set-aside designation was used for this award,...
- The Defense Logistics Agency awarded a delivery order valued at $5,329.18 to DMS Pharmaceutical Group Inc. for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor without a set-aside designation. The place of performance is...
- The Defense Logistics Agency awarded a $8,789.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Ondansetron HCl 4 mg tablets (500 count). The order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $12,021.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,558,233,358 units of Ondansetron HCL 4 mg tablets. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The IDC allows the DLA to issue firm...
- The Defense Logistics Agency awarded a delivery order valued at $6,708.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Ondansetron HCL 4 mg tablets (30-count units). The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, operates under a firm fixed-price structure with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,555.78 contract is for the delivery of ondansetron ODT 8 mg tablets to support military medical facilities worldwide. The delivery order is part of a larger $4,999,999 indefinite delivery contract (SPE2DB) with DMS Pharmaceutical Group to provide a broad range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on August 18, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with a ceiling value of $2,388.64. This firm fixed-price delivery order represents a continuation of the companies' established relationship under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million and extending through November 2026. The contract involves no set-aside...